Journal of comparative effectiveness research
The most recent articles from:
J Comp Eff Res
-
Randomized Controlled Trial Multicenter Study Comparative Study
Relative effectiveness of sunitinib versus everolimus in advanced pancreatic neuroendocrine tumors: an updated matching-adjusted indirect comparison.
A matching-adjusted indirect comparison (MAIC) of sunitinib and everolimus has been previously reported based on the RADIANT-3 everolimus trial. We performed an analysis using updated overall survival (OS) data based on sunitinib's trial (A6181111). ⋯ Findings indicate comparable PFS and OS with sunitinib and everolimus.
-
Randomized Controlled Trial Multicenter Study Comparative Study
An indirect comparison of intravenous and subcutaneous belimumab efficacy in patients with SLE and high disease activity.
To compare the efficacy of intravenous (IV) and subcutaneous (SC) belimumab plus standard therapy in patients with active, autoantibody-positive systemic lupus erythematosus and high disease activity (HDA). ⋯ This indirect treatment comparison provides further evidence of the efficacy of belimumab IV and SC in patients with systemic lupus erythematosus and HDA, compared with standard therapy.
-
Editorial Randomized Controlled Trial Multicenter Study
Accelerated versus standard care in hip fracture patients: does speed save lives?